Correlation Between Coloplast and Erria AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coloplast and Erria AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coloplast and Erria AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coloplast AS and Erria AS, you can compare the effects of market volatilities on Coloplast and Erria AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coloplast with a short position of Erria AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coloplast and Erria AS.

Diversification Opportunities for Coloplast and Erria AS

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Coloplast and Erria is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Coloplast AS and Erria AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erria AS and Coloplast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coloplast AS are associated (or correlated) with Erria AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erria AS has no effect on the direction of Coloplast i.e., Coloplast and Erria AS go up and down completely randomly.

Pair Corralation between Coloplast and Erria AS

Assuming the 90 days trading horizon Coloplast is expected to generate 4.75 times less return on investment than Erria AS. But when comparing it to its historical volatility, Coloplast AS is 9.53 times less risky than Erria AS. It trades about 0.28 of its potential returns per unit of risk. Erria AS is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  304.00  in Erria AS on October 25, 2024 and sell it today you would earn a total of  42.00  from holding Erria AS or generate 13.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy94.44%
ValuesDaily Returns

Coloplast AS  vs.  Erria AS

 Performance 
       Timeline  
Coloplast AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coloplast AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Coloplast is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Erria AS 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Erria AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Erria AS exhibited solid returns over the last few months and may actually be approaching a breakup point.

Coloplast and Erria AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coloplast and Erria AS

The main advantage of trading using opposite Coloplast and Erria AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coloplast position performs unexpectedly, Erria AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erria AS will offset losses from the drop in Erria AS's long position.
The idea behind Coloplast AS and Erria AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume